Contract 75N93023C00013
The Medical College Of Wisconsin, Inc. · Department Of Health And Human Services · July 21, 2025
The Medical College Of Wisconsin, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 21, 2025 for $1.18 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Milwaukee, WI. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost no fee contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $3.28 million.
Contract details
- PIID
- 75N93023C00013
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Milwaukee, WI
- First action
- July 21, 2025
- Latest action
- March 18, 2026
Description
MITIGATION OF MULTI-ORGAN DELAYED EFFECTS OF ACUTE RADIATION EXPOSURE (DEARE) WITH ACE-INHIBITOR LISINOPRIL
Modification timeline
-
March 18, 2026Mod P00009 · Other Administrative Action$3.28M
-
August 5, 2025Mod P00008 · Funding Only Action$3.28M
-
July 21, 2025Mod P00007 · Exercise An Option$3.10M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023C00013?
Contract 75N93023C00013 is a federal contract awarded to The Medical College Of Wisconsin, Inc. by Department Of Health And Human Services on July 21, 2025 for $1.18 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93023C00013?
The Medical College Of Wisconsin, Inc. won contract 75N93023C00013 from Department Of Health And Human Services.
How much is contract 75N93023C00013 worth?
Contract 75N93023C00013 has obligated $1.18 million to date, with a total potential value of $3.28 million if all options are exercised.